NasdaqCM - Delayed Quote USD

Virax Biolabs Group Limited (VRAX)

0.6580 -0.0220 (-3.24%)
At close: April 23 at 4:00 PM EDT
All numbers in thousands
Download
Breakdown
3/31/2023
3/31/2022
3/31/2021
Total Assets
9,812.4160
48.7060
39.6210
Total Liabilities Net Minority Interest
908.4010
1,245.4140
871.4350
Total Equity Gross Minority Interest
8,904.0150
-1,196.7080
-831.8140
Total Capitalization
9,126.4140
-974.5780
-650.6820
Common Stock Equity
9,126.4140
-974.5780
-650.6820
Net Tangible Assets
8,948.0110
-974.5780
-650.6820
Working Capital
8,725.6120
-1,196.7080
-831.8140
Invested Capital
9,272.6640
-974.5780
-650.6820
Tangible Book Value
8,948.0110
-974.5780
-650.6820
Total Debt
146.2500
--
--
Share Issued
1,554.7080
1,137.4090
1,137.4090
Ordinary Shares Number
1,554.7080
1,137.4090
1,137.4090
3/31/2021 - 7/21/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

QNRX Quoin Pharmaceuticals, Ltd.
0.6600
0.00%
 
SPRC SciSparc Ltd.
1.2300
+0.82%
 
REVB Revelation Biosciences, Inc.
2.0700
+0.98%
 
KPRX Kiora Pharmaceuticals, Inc.
0.5795
+19.48%
 
RNAZ TransCode Therapeutics, Inc.
0.4599
+0.22%
 
ENSC Ensysce Biosciences, Inc.
0.5583
+0.96%
 
NRBO NeuroBo Pharmaceuticals, Inc.
3.0200
-3.21%
 
KTTA Pasithea Therapeutics Corp.
7.09
+4.26%
 
CMRA Comera Life Sciences Holdings, Inc.
0.0410
0.00%
 
SNTI Senti Biosciences, Inc.
0.3000
+6.80%